- CorMedix Inc. (NYSE:CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
- Bioamber Inc (NYSE:BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
- The Medicines Company (NASDAQ:MDCO) shares dipped 20.9 percent to $41.62.
- Innocoll Holdings PLC (NASDAQ:INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
- Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
- Esperion Therapeutics Inc (NASDAQ:ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
- AmTrust Financial Services Inc (NASDAQ:AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
- Qualstar Corporation (NASDAQ:QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 million.
- TOP SHIPS Inc (NASDAQ:TOPS) shares fell 14.1 percent to $1.89 after surging 109.52 percent on Thursday.
- Caleres Inc (NYSE:CAL) shares dropped 12.8 percent to $27.59 after the company posted weaker-than-expected earnings for its fourth quarter.
- Exa Corp (NASDAQ:EXA) declined 12.8 percent to $13.68. Exa reported Q4 adjusted earnings of $0.05 per share on revenue of $19.5 million. Canaccord Genuity downgraded Exa from Buy to Hold.
- Veritiv Corp (NYSE:VRTV) shares dropped 11.7 percent to $51.95. Veritiv priced its 1.8 million share secondary offering of common stock at $54.85 per share.
- AXT Inc (NASDAQ:AXTI) declined 10.6 percent to $5.90 after dropping 10.81 percent on Thursday. B. Riley downgraded AXT from Buy to Neutral.
- GSV Capital Corp (NASDAQ:GSVC) fell 10.1 percent to $4.81. GSV Capital reported a Q4 loss of $31.5 million.
- Cerulean Pharma Inc (NASDAQ:CERU) shares declined 8.4 percent to $2.82 after rising 3.36 percent on Thursday.
- Vuzix Corporation (NASDAQ:VUZI) shares fell 7.7 percent to $6.64 after the company issued a business update and reported Q4 financial results.
- Editas Medicine Inc (NASDAQ:EDIT) dropped 7.5 percent to $23.04. Editas Medicine priced an underwritten offering of 4,000,000 shares at $22.50 per share.
- Diana Containerships Inc (NASDAQ:DCIX) fell 5.1 percent to $2.64 after surging 12.55 percent on Thursday.
- Ocular Therapeutix Inc (NASDAQ:OCUL) fell 4.5 percent to $9.53 after gaining 12.13 percent on Thursday.
- Inventure Foods Inc (NASDAQ:SNAK) fell 3 percent to $4.89 after the company filed to delay its Annual Report on Form 10-K for fiscal 2016.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!